Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.
Also called NCT05657444
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 380 participants
- Registry
-
NCT05657444
-
- Other papers using this trial's data
- Intra-arterial tenecteplase during thrombectomy for acute ischemic stroke: the BRETIS-TNK2 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05657444. Randomized; single masking; primary purpose treatment. Start 2023-03-21 (actual); primary completion 2025-03-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Tenecteplase
- Lead sponsor
- General Hospital of Shenyang Military Region
- Collaborator
- Cerebrovascular Disease Collaboration & Innovation Alliance of Liaoning
Record details
- Record id
cardio:ct-nct05657444- Content hash
05d2d325723f02edc9eab260aabfb9d855c78f4c9529e528b8fb4e0a4db03353